Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Glioblastomas (GBMs) are the most lethal malignancy in the human tumor. A significant portion of the vascular endothelium has a neoplastic origin, and the glioblastomas stem-like cells (GSCs) have the potential of transdifferentiating to endothelial like cells. This transdifferentiation process involves a series of cytokines, including vascular endothelial growth factor (VEGF), transforming growth factor beta, and interleukin-8(IL-8). IL-8 is a chemokine with a defining CXC motif secreted by many kinds of cells. In human gliomas, IL-8 is expressed and secreted at high levels both in vitro and in vivo. The level of IL-8 is associated with the histological grade of glioma, and the most malignant form of glioblastoma shows the highest expression in necrotic cells, hypoxia conditions may stimulate IL-8 expression. And in a glioma niche, endothelial cells and TDEC can be stimulated by IL-8 in hypoxia condition.